Product Acquisition/Disposal

October 21, 2019

Bavarian’s chance to draw a line under oncology

The Danish group seizes an opportunity to focus on what it does best, but its ill-fated flirtation with oncology continues.

October 15, 2019

Admedus moves from one unlikely area to another

A product sale nets the Australian company some much-needed cash, but its plan for the future is highly questionable.

November 01, 2018

Flipping for the win at Strongbridge Biopharma

Strongbridge's deal with Novo Nordisk over Macrilen tops up the former's cash pile and pays off debt just 10 months after the company licensed the project from…

March 21, 2018

Amid mounting questions, Celgene keeps spending

March 16, 2018

Snippet roundup: J&J shrinks, while Vernalis vanishes altogether

March 09, 2018

Interview – Evotec gets paid to take on Sanofi’s anti-infectives

November 17, 2017

Snippet roundup: Three approvals and more pricing headaches

November 10, 2017

Snippet roundup: smart dealmaking by Sanofi – Valeant, not so much

August 25, 2017

Snippet roundup: Adamas and Alexion score approvals and Amgen gets the price right

March 17, 2017

Astra’s mistakes mount up

March 17, 2017

Astra’s mistakes mount up

Load More